» Articles » PMID: 15523622

Genotype-phenotype Correlations for a Wide Spectrum of Mutations in the Wilson Disease Gene (ATP7B)

Overview
Specialty Genetics
Date 2004 Nov 4
PMID 15523622
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Wilson disease (WND) is caused by mutations in the ATP7B gene and exhibits substantial allelic heterogeneity. In this study we report the results of molecular analyses of 20 WND families not described previously. When combined with our prior results, the cohort includes 93 index patients from 69 unrelated families. Twenty different mutations accounted for 86% of the WND chromosomes. The most frequent were p.H1069Q (35%), p.R969Q (12%), c.2530delA (7%), p.L936X (7%), p.Q289X (7%), and p.I1148T (3%). We also present here a detailed phenotypic assessment for patients whose molecular result was previously reported. Thirty cases were homozygous for 9 different mutations, 13 of which were homozygous for p.H1069Q, and 7 for p.R969Q. Mutations p.H1069Q and p.R969Q appeared to confer a milder disease as patients showed disease onset at a later age, and were associated with milder severity when found in trans with severe mutations. Predicted nonsense and frameshift mutations were associated with severe phenotypic expression with earlier disease onset and lower ceruloplasmin values. WND can be treated by copper-chelation therapy, particularly if the disease is diagnosed before irreversible tissue damage occurs. Our results on the effect of predicted nonsense and frameshift mutations are especially important for early medical intervention in presymptomatic infants and children with these genotypes.

Citing Articles

Spectrum of Pathogenic Variants of the ATP7B Gene and Genotype-Phenotype Correlation in Eastern Eurasian Patient Cohorts with Wilson's Disease.

Garbuz M, Ovchinnikova E, Ovchinnikova A, Vinokurova V, Aristarkhova Y, Kuziakova O Biomedicines. 2025; 12(12.

PMID: 39767741 PMC: 11673475. DOI: 10.3390/biomedicines12122833.


Phenotypic and genetic characterization of children with Wilson Disease from Northeast China.

Zhang T, Song W, Mao Z BMC Pediatr. 2024; 24(1):576.

PMID: 39267050 PMC: 11391784. DOI: 10.1186/s12887-024-05045-x.


Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson's Disease.

Choi W, Cha S, Kim K Cells. 2024; 13(14.

PMID: 39056796 PMC: 11274827. DOI: 10.3390/cells13141214.


Epidemiology of Wilson's Disease and Pathogenic Variants of the Gene Leading to Diversified Protein Disfunctions.

Ovchinnikova E, Garbuz M, Ovchinnikova A, Kumeiko V Int J Mol Sci. 2024; 25(4).

PMID: 38397079 PMC: 10889319. DOI: 10.3390/ijms25042402.


Clinical, biochemical and molecular characterization of Wilson's disease in Moroccan patients.

Lafhal K, Sabir E, Hakmaoui A, Hammoud M, Aimrane A, Najeh S Mol Genet Metab Rep. 2023; 36:100984.

PMID: 37323222 PMC: 10267639. DOI: 10.1016/j.ymgmr.2023.100984.